Back

Frontiers in Endocrinology

20 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
The Adipo-B Index as a Novel Integrator of Glycemic and Lipid Homeostasis: a Multiple-Therapy Validation Study
2026-02-16 endocrinology 10.64898/2026.02.16.26346332
#1 (19.1%)
Show abstract

ObjectiveTo introduce and evaluate the clinical utility of the "adipo-B index" as a novel metric of the adipose tissue-pancreatic beta cell axis. To our knowledge, no prior clinical metric has integrated adipose tissue insulin resistance and pancreatic beta-cell function into a single index applicable across therapeutic classes. MethodsTreatment-naive subjects with T2DM received monotherapy with modified traditional diet for diabetes (MJDD, n=61), canagliflozin (n=67), pioglitazone (n=54), or s...

2
Divergent uric acid responses to traditional Japanese diet and the DPP-4 inhibitor alogliptin in drug-naive subjects with type 2 diabetes
2026-02-25 endocrinology 10.64898/2026.02.21.26346799
Top 0.1% (11.3%)
Show abstract

Uric acid (UA) is traditionally regarded as a metabolic risk marker; however, its dynamic behavior during glucose-lowering therapy remains incompletely understood. We compared UA responses to a modified traditional Japanese diet (MJDD) and the DPP-4 inhibitor alogliptin in patients with early-stage type 2 diabetes mellitus (T2DM). In this prospective observational study, drug-naive patients received MJDD (n=58) or alogliptin (n=52) monotherapy for 3 months. Changes ({Delta}) in serum UA were ana...

3
Early, Late, & Self-Selected Time-Restricted Eating: Impact on Hepatic Fat, Liver Health, & Fecal Microbiota in Adults with Overweight or Obesity
2026-01-19 endocrinology 10.64898/2026.01.17.26344338
Top 0.1% (10.9%)
Show abstract

Background and aimsThe optimal eating window for time-restricted eating (TRE) remains unclear. We investigated the effects of 8-hour TRE combined with usual care (UC, a Mediterranean diet-based education program), versus UC alone over 12 weeks on hepatic fat fraction, liver health markers, and fecal microbiota in adults with overweight or obesity. MethodsIn this multicenter randomized trial, participants (50% women) were assigned to UC (n=49), early TRE (n=49), late TRE (n=52), or self-selected...

4
Epidemiological characteristics of newly diagnosed Graves' disease following the widespread outbreak of COVID-19 in Guangzhou, China
2025-12-29 endocrinology 10.64898/2025.12.28.25343112
Top 0.1% (10.4%)
Show abstract

ObjectivesThere is currently insufficient evidence linking COVID-19 infection with Graves disease (GD). Following the complete lifting of COVID-19 restrictions on December 13, 2022, widespread infection in Guangzhou provides a basis for this study. This research aims to investigate the correlation between COVID-19 infection and GD onset, explore the epidemiological characteristics of newly diagnosed GD post-infection, and offer a scientific basis for treatment. MethodsThe study population inclu...

5
Hepatic and abdominal adiposity in type 2 diabetes as assessed with machine learning on CT scans
2025-12-18 endocrinology 10.64898/2025.12.16.25342409
Top 0.2% (9.8%)
Show abstract

AimsThe distribution of abdominal adipose depots and their mechanistic links to type 2 diabetes remain incompletely understood. This study elucidated the relationship between type 2 diabetes presence and quantitative abdominal imaging traits, including hepatic steatosis, liver and spleen size, and adipose distribution, using unenhanced computed tomography (CT) scans from a large-scale, racially diverse, disease-focused medical biobank. Materials and MethodsDeep learning algorithms were applied ...

6
Association between adipokines and glycemia in children under age 8: the PROGRESS cohort of Mexico
2026-01-22 endocrinology 10.64898/2026.01.20.26344469
Top 0.2% (9.8%)
Show abstract

BackgroundThe role of adipokines in childhood glycemia is poorly understood. We investigate the longitudinal association between adipokines and glycemia in a cohort of children in Mexico City. MethodsChildren from the Programming Research in Obesity, Growth, Environment, and Social Stressors (PROGRESS) cohort (948 children, 52% male) were followed longitudinally from birth. Leptin, adiponectin, glucose, and HbA1c were measured at four, six, and eight years, and fasting insulin at eight years. A...

7
CBC-derived leukocyte differential indices in relation to insulin resistance in women with polycystic ovary syndrome: a cross- sectional study
2025-12-27 endocrinology 10.64898/2025.12.23.25342888
Top 0.2% (9.0%)
Show abstract

ContextPolycystic ovary syndrome (PCOS) is characterized by hyperandrogenism and frequent metabolic disturbances, including insulin resistance (IR), and is commonly accompanied by chronic low-grade inflammation. Complete blood count (CBC)-derived indices provide inexpensive markers reflecting systemic inflammatory and hematologic status; however, their relationships with androgen-related features in PCOS remain incompletely characterized. ObjectiveTo evaluate associations between androgen-relat...

8
Data Driven Endocrine Metabolic Phenotypes in Young Women With Polycystic Ovary Syndrome and Associations With Cardiometabolic Risk Markers
2026-03-03 endocrinology 10.64898/2026.02.25.26346893
Top 0.3% (8.7%)
Show abstract

ContextPolycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder associated with reproductive dysfunction and long-term cardiometabolic risk. Traditional phenotype classifications based on diagnostic criteria may not fully capture the multidimensional biological variability underlying endocrine and metabolic risk profiles, particularly in young women. ObjectiveTo identify data-driven endocrine-metabolic phenotypes in young women with PCOS and evaluate their association with establi...

9
Weight trajectories after last Tirzepatide or Semaglutide prescription across a federated health network
2026-01-28 endocrinology 10.64898/2026.01.26.26344839
Top 0.3% (8.6%)
Show abstract

GLP-1 receptor agonist (GLP-1RA) discontinuation has been associated with weight regain. However, the real-world association between discontinuation of GLP-1RA prescriptions and weight change has not been explored. We assessed weight trajectories of 4,182 patients in the six months following their last GLP-1RA prescription. Approximately two-thirds of patients showed stable weight or continued weight loss during this period post the last known GLP-1RA prescription. In a representative subset of ...

10
Integrated miRNA_mRNA Analysis Reveals Dysregulated Regulatory Networks in Visceral Adipose Tissue Linked to Obesity and Type 2 Diabetes
2026-02-09 endocrinology 10.64898/2026.02.06.26345741
Top 0.3% (8.3%)
Show abstract

Obesity-driven type 2 diabetes (T2D) is characterized by pathological alterations in visceral white adipose tissue (vWAT). While microRNAs (miRNAs) are key post-transcriptional regulators, comprehensive human vWAT profiling across metabolic states remains limited. This study characterized vWAT miRNA expression in lean, obese, and obese+T2D individuals to identify regulatory networks associated with metabolic failure. Deep miRNA sequencing was performed on vWAT samples from a discovery cohort, fo...

11
Discordance between HbA1C and Glucose Tests for the Diagnosis of Prediabetes in a Filipino-American Cohort
2026-01-11 endocrinology 10.64898/2026.01.09.26343777
Top 0.4% (8.2%)
Show abstract

BackgroundThe diagnostic accuracy of HbA1C for prediabetes has been questioned due to its discordance with fasting plasma glucose (FPG) and 2 h oral glucose tolerance test (OGTT) glucose in non-white populations. This study aims to estimate concordance in the diagnosis of prediabetes using HbA1C FPG, and OGTT in a Filipino-American cohort. MethodsCross-sectional data from 149 Filipino-Americans without known diabetes living in the San Francisco Bay Area were used to compare prevalence of predia...

12
A Prospective Controlled Study of Postpartum Breastfeeding Rates in Women with Type 2 Diabetes: Does Obesity Matter More Than Diabetes?
2026-01-21 endocrinology 10.64898/2026.01.18.26344373
Top 0.4% (8.1%)
Show abstract

Breastfeeding is associated with metabolic benefits for women with type 2 diabetes and their infants, yet breastfeeding rates in these women are poorly described. Obesity is associated with type 2 diabetes, and lower breastfeeding rates, making it difficult to disentangle type 2 diabetes vs. obesity effects on breastfeeding. AimsThe primary objective was to examine breastfeeding rates in women with type 2 diabetes, compared to normoglycaemic women with either (1) matched body mass index (BMI) o...

13
Glycated Protein Precipitation Index: Bridging the Gap Between Short-Term and Long-Term Glycemic Markers
2025-12-15 endocrinology 10.64898/2025.12.12.25342172
Top 0.4% (8.0%)
Show abstract

BackgroundCurrent glycemic monitoring exhibits a critical temporal gap between fructosamine (14-21 days) and HbA1c (90-120 days), limiting timely therapeutic adjustments. The Glycated Protein Precipitation Index (GPPI) represents a novel biomarker potentially bridging this interval. ObjectiveTo validate GPPIs correlation with established glycemic markers and determine its clinical utility for intermediate-term glycemic assessment. Methods: This prospective validation study will enroll 200 diabe...

14
The KIND cohort profile: longitudinal assessment of glycaemic management and neurophysiological outcomes in paediatric type 1 diabetes in Switzerland
2026-01-13 endocrinology 10.64898/2026.01.11.26343881
Top 0.4% (8.0%)
Show abstract

1PurposeThe KIND (KINder mit Diabetes) cohort investigates diabetic peripheral neuropathy (DPN) in paediatric type 1 diabetes (T1D). Current guidelines recommend DPN screening at puberty or from 11 years and 2-5 years after T1D diagnosis, yet subclinical neurophysiological changes occur within the first 2 years. The cohort examines: (1) longitudinal associations between glycaemic metrics (HbA1c and continuous glucose monitoring-derived variability metrics) and peripheral nerve function and struc...

15
Efficacy and safety of Youth-derived Fecal Microbiota Transplantation among adults with Type 1 Diabetes Mellitus: A protocol of pilot randomized controlled trial
2026-02-04 endocrinology 10.64898/2026.02.03.26345459
Top 0.4% (8.0%)
Show abstract

BackgroundDysbiosis of gut microbiota plays a key role in type 1 diabetes mellitus (T1DM). Fecal microbiota transplantation represents a novel therapeutic avenue. We hypothesize that youth-derived fecal microbiota transplantation (yFMT) can remodel the gut microecosystem and improve clinical outcomes. This study aims to investigate the efficacy and safety of orally administered yFMT capsules in adults with T1DM. Methods and analysisThis single-center, randomized, double-blind, placebo-controlle...

16
Engagement With a Breath-Based Metabolic Device Is Associated with Greater Weight Loss in Self-Reported Real-World GLP-1RA Users
2026-02-24 endocrinology 10.64898/2026.02.22.26346841
Top 0.5% (7.8%)
Show abstract

BackgroundDigital health self-monitoring tools are widely used to support weight management and metabolic health. Higher engagement with these tools is often associated with better clinical outcomes; however, real-world engagement-outcome relationships for consumer metabolic monitoring devices remain incompletely characterized, particularly in heterogeneous user populations. ObjectiveTo evaluate whether engagement with a portable breath-based metabolic device (Lumen; Metaflow Ltd.) is associate...

17
Assessment of fatal cardiovascular disease risk using data-driven diabetes subgroups and SCORE2-Diabetes in 24,943 adults in Mexico City
2025-12-16 endocrinology 10.64898/2025.12.15.25342299
Top 0.5% (7.8%)
Show abstract

BACKGROUNDCardiovascular disease (CVD) is a leading cause of diabetes-related mortality in Mexico. Although diabetes subgroups capture underlying disease heterogeneity, their association and utility for risk prediction for fatal CVD in Mexican adults remain unclear. METHODSWe analyzed 24,943 adults with diabetes from the Mexico City Prospective Study. Participants were classified into mild obesity-related (MOD), severe insulin-deficient (SIDD), severe insulin-resistant (SIRD), and mild age-rela...

18
Differential Metabolic Signatures of Cushing's Disease Patients Dependent on their Obesity Status
2026-02-27 endocrinology 10.64898/2026.02.25.26346994
Top 0.5% (7.4%)
Show abstract

Cushings disease is caused by the overproduction of cortisol. The effects of this disease are well known in a general population, including high blood pressure, diabetes, and weight gain. Cushings disease causes both obesity and metabolic related symptoms, and it can be difficult to discern the obesity-dependent from the obesity-independent mechanisms of Cushings disease. To identify patients with Cushings disease, we identified 476 Michigan Medicine patients between January 1st 2000-2025 along ...

19
High Prevalence of Adolescents At Risk for PCOS and Links to Genetic Susceptibility to PCOS
2025-12-29 endocrinology 10.64898/2025.12.19.25342512
Top 0.5% (7.2%)
Show abstract

ImportanceDiagnosis of polycystic ovary syndrome (PCOS) in adolescence is challenging because menstrual irregularity and hyperandrogenism are common in adolescents. Recent international guidelines highlighted an at risk for PCOS category based on either menstrual regularity or hyperandrogenism; however, its population prevalence and genetic correlates remain unknown. ObjectiveTo estimate the prevalence of PCOS and at risk for PCOS in adolescence and evaluate associations with genetic risk for P...

20
The Relationship Between Clinical Profile, Glycemic Parameters And Hypoglycemia In Type 1 Diabetes Pediatric Patients
2025-12-27 endocrinology 10.64898/2025.12.19.25342708
Top 0.6% (7.2%)
Show abstract

Background/ObjectivesOur objective was to understand the role of clinical and continuous glucose monitoring (CGM) parameters in predicting the risk of hypoglycemia in type 1 diabetes pediatric patients. MethodsPediatric patients with type 1 diabetes (n=71) at the Oradea County Clinical Emergency Hospital, Romania, underwentCGM during their initial visit and were followed for at least 6 months, with in-clinic visits every 3 months. Age, body mass index, time in range, mean daily glucose(MDG) con...